Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007
作者： Aron Goldhirsch , WC Wood , RD Gelber , AS Coates , B Thürlimann
关键词: Trastuzumab 、 Systemic therapy 、 MEDLINE 、 Immunology 、 Intensive care medicine 、 Disease 、 Endocrine system 、 Cancer 、 Chemotherapy regimen 、 Breast cancer 、 Medicine
摘要: … Lapatinib has shown significant efficacy (together with capecitabine) in advanced breast cancer after failure of trastuzumab [36]. Its testing in the adjuvant setting is imminent [37]. …
annalsofoncology.org
ganjoho.org
oup.com
oxfordjournals.org
elsevier.com参考文章(93)
Therese Sørlie, Molecular classification of breast tumors: toward improved diagnostics and treatments. Methods of Molecular Biology. ,vol. 360, pp. 91- 114 ,(2007) , 10.1385/1-59745-165-7:91
Niels Kroman, Andrew Tutt, Maj-Britt Jensen, Jan Wohlfahrt, Henning T Mouridsen, Per Kragh Andersen, Mads Melbye, Gillian Ross, Factors influencing the effect of age on prognosis in breast cancer: population based study Commentary: much still to learn about relations between tumour biology, prognosis, and treatment outcome in early breast cancer BMJ. ,vol. 320, pp. 474- 479 ,(2000) , 10.1136/BMJ.320.7233.474
Suleiman Massarweh, Rachel Schiff, C. Kent Osborne, Jiang Shou, Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clinical Cancer Research. ,vol. 11, ,(2005)
Shari Gelber, Alan S. Coates, Aron Goldhirsch, Monica Castiglione-Gertsch, Gianluigi Marini, Jurij Lindtner, David Z. Edelmann, Anne Gudgeon, Vernon Harvey, Richard D. Gelber, Effect of Pregnancy on Overall Survival After the Diagnosis of Early-Stage Breast Cancer Journal of Clinical Oncology. ,vol. 19, pp. 1671- 1675 ,(2001) , 10.1200/JCO.2001.19.6.1671
M. Martin, S33 Benefit with adjuvant taxanes and endocrine responsiveness in breast cancer (BC) The Breast. ,vol. 16, ,(2007) , 10.1016/S0960-9776(07)70056-5
Eric A. Ariazi, Joan S. Lewis-Wambi, Shaun D. Gill, Jennifer R. Pyle, Jennifer L. Ariazi, Helen R. Kim, Catherine G.N. Sharma, Fernando Cordera, Heather A. Shupp, Tianyu Li, V. Craig Jordan, Emerging principles for the development of resistance to antihormonal therapy: Implications for the clinical utility of fulvestrant The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 102, pp. 128- 138 ,(2006) , 10.1016/J.JSBMB.2006.09.003
Stine S. Korreman, Anders N. Pedersen, Lasse Rye Aarup, Trine J. Nøttrup, Lena Specht, Håkan Nyström, Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer International Journal of Radiation Oncology*Biology*Physics. ,vol. 65, pp. 1375- 1380 ,(2006) , 10.1016/J.IJROBP.2006.03.046
Hyman B. Muss, Targeted therapy for metastatic breast cancer The New England Journal of Medicine. ,vol. 355, pp. 2783- 2785 ,(2006) , 10.1056/NEJME068260
Joseph A. Sparano, TAILORx: trial assigning individualized options for treatment (Rx). Clinical Breast Cancer. ,vol. 7, pp. 347- 350 ,(2006) , 10.3816/CBC.2006.N.051
Gildy V. Babiera, Roshni Rao, Lei Feng, Funda Meric-Bernstam, Henry M. Kuerer, S. Eva Singletary, Kelly K. Hunt, Merrick I. Ross, Karin M. Gwyn, Barry W. Feig, Frederick C. Ames, Gabriel N. Hortobagyi, Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor Annals of Surgical Oncology. ,vol. 13, pp. 776- 782 ,(2006) , 10.1245/ASO.2006.03.033